tiprankstipranks
Trending News
More News >
LakeShore Biopharma (LSBCF)
OTHER OTC:LSBCF
US Market

LakeShore Biopharma (LSBCF) Income Statement

Compare
92 Followers

LakeShore Biopharma Income Statement

Last quarter (Q4 2024), LakeShore Biopharma's total revenue was ¥135.53M, an increase of 27.71% from the same quarter last year. In Q4, LakeShore Biopharma's net income was ¥-181.41M. See LakeShore Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 614.96M¥ 573.42M¥ 687.20M¥ 502.95M¥ 257.02M
Gross Profit
¥ 507.19M¥ 455.73M¥ 533.84M¥ 381.49M¥ 197.36M
Operating Expenses
¥ 593.48M¥ 901.56M¥ 673.22M¥ 500.45M¥ 323.21M
Depreciation and Amortization
¥ 36.65M¥ 42.19M¥ 36.69M¥ 31.15M¥ 27.91M
EBITDA
¥ -48.54M¥ -368.66M¥ -76.80M¥ -67.20M¥ -116.78M
Operating Income
¥ -86.29M¥ -445.83M¥ -139.38M¥ -118.96M¥ -125.85M
Other Income/Expenses
¥ -14.64M¥ -9.36M¥ -142.95M¥ -112.77M¥ -65.13M
Pretax Income
¥ -100.93M¥ -455.19M¥ -282.34M¥ -231.73M¥ -190.98M
Net Income
¥ -99.98M¥ -433.46M¥ -145.48M¥ -236.67M¥ -191.83M
Per Share Metrics
Basic EPS
¥ -0.94¥ -4.05¥ -1.88¥ -0.02¥ -6.67
Diluted EPS
¥ -0.94¥ -4.05¥ -1.88¥ -0.02¥ -6.67
Weighted Average Shares Outstanding
106.92M 106.92M 77.42M 29.50M 28.75M
Weighted Average Shares Outstanding (Diluted)
106.92M 106.92M 77.42M 29.50M 28.75M
Currency in CNY

LakeShore Biopharma Earnings and Revenue History